Varicose vein in patients under the age of 40: A multicenter case-control study

Abstract

Objective

To assess the risk factors for varicose veins in patients under the age of 40 and the long-term results of surgery.

Methods

This multicenter case-control study comprised patients who received great saphenous vein stripping and ambulatory phlebectomy between January 2014 and December 2015 and were followed for at least 5 years. Patients under the age of 40 were assigned to Group 1. Patients in Group 2 were selected in a 3:1 ratio by matching their CEAP classification to those in Group 1. We studied their demographics, risk factors, and follow-up findings.

Results

There were 42 patients (mean age 35) in Group 1 and 126 patients (mean age 57) in Group 2. Group 2 patients had a higher prevalence of hypertension (16% vs 2%, p = .022). The proportions of C2, C3, C4, C5, and C6 were 52%, 10%, 24%, 10%, and 5%, respectively. For risk factors, only family history was more prevalent in Group 1 (odds ratio 4.9, 95% confidence interval 2.3–10.4). The course of the disease was shorter in Group 1 (p = .003). During a mean follow-up of 79 months, there were no difference in the recurrences of varicose vein, Venous Clinical Severity Score, or Aberdeen Varicose Vein Questionnaire scores (p > .05), which indicated similar 5-year surgery efficacy between the two groups.

Conclusion

Family history was more prevalent and the course of the disease was shorter among young patients with varicose veins. The 5-year prognosis of surgery was satisfactory despite the age of receiving the treatment.

Keywords

Varicose veins case-control study young family history

Get full access to this article

View all access options for this article.

References

Tisi

. Varicose veins. BMJ Clin Evid 2011; 2011: 0212.

Hamdan

. Management of varicose veins and venous insufficiency. JAMA 2012; 308(24): 2612–2621.

Brown

Obi

Cronenwett

, et al. Outcomes after truncal ablation with or without concomitant phlebectomy for isolated symptomatic varicose veins (C2 disease). J Vasc Surg Venous Lymphat Disord 2021; 9(2): 369–376.

DePopas

Brown

. Varicose veins and lower extremity venous insufficiency. Semin Interv Radiol 2018; 35(1): 56–61.

Beebe-Dimmer

Pfeifer

Engle

, et al. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol 2005; 15(3): 175–184.

Evans

Fowkes

Ruckley

, et al. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidemiol Community Health 1999; 53(3): 149–153.

Hassanin

Aherne

Greene

, et al. A systematic review and meta-analysis of comparative studies comparing nonthermal versus thermal endovenous ablation in superficial venous incompetence. J Vasc Surg Venous Lymphat Disord 2019; 7(6): 902–913.

Anwar

Georgiadis

Shalhoub

, et al. A review of familial, genetic, and congenital aspects of primary varicose vein disease. Circ Cardiovasc Genet 2012; 5(4): 460–466.

Wittens

Davies

Bækgaard

, et al. Editor’s choice - Management of chronic venous disease: clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2015; 49(6): 678–737.

10.

Lurie

Passman

Meisner

, et al. The 2020 update of the CEAP classification system and reporting standards. J Vasc Surg Venous Lymphat Disord 2020; 8(3): 342–352.

11.

Zöller

Sundquist

, et al. Family history and risk of hospital treatment for varicose veins in Sweden. Br J Surg 2012; 99(7): 948–953.

12.

Pascarella

Shortell

. Chronic venous disorders: nonoperative management. In: Sidawy

Perler

(eds). Rutherford’s vascular surgery and endovascular therapy. 9th ed. Netherlands: Elsevier, 2019, p. 2065.

13.

Vasquez

Munschauer

. Venous Clinical Severity Score and quality-of-life assessment tools: application to vein practice. Phlebology 2008; 23(6): 259–275.

14.

Garratt

Macdonald

Ruta

, et al. Towards measurement of outcome for patients with varicose veins. Qual Health Care 1993; 2(1): 5–10.

15.

Kostas

Ioannou

Touloupakis

, et al. Recurrent varicose veins after surgery: a new appraisal of a common and complex problem in vascular surgery. Eur J Vasc Endovasc Surg 2004; 27(3): 275–282.

16.

Gohel

Heatley

Liu

, et al. A randomized trial of early endovenous ablation in venous ulceration. N Engl J Med 2018; 378(22): 2105–2114.

17.

Davies

. The seriousness of chronic venous disease: a review of real-world evidence. Adv Ther 2019; 36(Suppl 1): 5–12.

18.

Lim

Davies

. Pathogenesis of primary varicose veins. Br J Surg 2009; 96(11): 1231–1242.

19.

Oklu

Habito

Mayr

, et al. Pathogenesis of varicose veins. J Vasc Interv Radiol 2012; 23(1): 33–39; quiz 40.

20.

Kusagawa

Ozu

Inoue

, et al. Clinical results 5 years after great saphenous vein stripping. Ann Vasc Dis 2021; 14(2): 112–117.

21.

Brittenden

Cooper

Dimitrova

, et al. Five-year outcomes of a randomized trial of treatments for varicose veins. N Engl J Med 2019; 381(10): 912–922.

22.

Rutherford

Padberg

Jr. Comerota

, et al. Venous severity scoring: an adjunct to venous outcome assessment. J Vasc Surg 2000; 31(6): 1307–1312.

23.

Vasquez

Rabe

McLafferty

, et al. Revision of the venous clinical severity score: venous outcomes consensus statement: special communication of the American Venous Forum Ad Hoc Outcomes Working Group. J Vasc Surg 2010; 52(5): 1387–1396.

24.

Gloviczki

Comerota

Dalsing

, et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011; 53(5 Suppl): 2S–48S.

25.

Lurie

Lal

Antignani

, et al. Compression therapy after invasive treatment of superficial veins of the lower extremities: clinical practice guidelines of the American Venous Forum, Society for Vascular Surgery, American College of Phlebology, Society for Vascular Medicine, and International Union of Phlebology. J Vasc Surg Venous Lymphat Disord 2019; 7(1): 17–28.